Bio-Imaging appoints new president for data capture division

Bio-Imaging Technologies has appointed Peter S. Benton as president of its Phoenix Data Systems (PDS) division, a provider of electronic data capture services.

Benton will succeed William Claypool, MD, who is leaving PDS to start a pharmaceutical development consulting company, Pennmark Associates.

Benton has more than 20 years of experience, within the pharmaceutical research industry in operations, management, strategic planning and mergers and acquisitions. 

Most recently, he was chief operating officer of an eClinical technology services company, where he was responsible for overall operations, including project management, applications development, quality control, customer support and technology integration.

Previously, he was associated with Johnson & Johnson’s Pharmaceutical business, where he served as vice president of central planning.

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.